Radiation Biology & Protection
Stochastic vs deterministic effects, dose limits, and ALARA
Quick Answer
Radiation effects are either stochastic (probability of harm — chiefly cancer — rises with dose, no threshold under the linear-no-threshold model; severity is fixed) or deterministic / tissue reactions (occur above a threshold, with severity rising with dose — skin injury, marrow suppression, cataract). Protection follows ALARA (as low as reasonably achievable) using time, distance, and shielding, within regulatory dose limits. Diagnostic nuclear medicine operates in the stochastic-risk range; therapy dosimetry manages deterministic organ limits (marrow, kidney, lung, salivary).
Key Quantities
| Quantity | Unit | Meaning |
|---|---|---|
| Absorbed dose | gray (Gy) | Energy deposited per unit mass |
| Equivalent dose | sievert (Sv) | Absorbed dose × radiation weighting factor (β/γ = 1; α = 20) |
| Effective dose | sievert (Sv) | Equivalent dose × tissue weighting factors — whole-body stochastic-risk scale |
Effective dose lets disparate procedures be compared on one stochastic-risk scale (e.g., an FDG-PET/CT vs a bone scan).
Stochastic vs Deterministic
| Stochastic | Deterministic (tissue reaction) | |
|---|---|---|
| Threshold | None (LNT assumed) | Yes |
| Dose–effect | Probability ↑ with dose | Severity ↑ with dose above threshold |
| Latency | Years (cancer) | Hours–weeks (acute) or years (cataract) |
| Examples | Cancer, heritable effects | Skin erythema, marrow suppression, cataract, fertility, fetal effects |
Dose Limits (Representative, ICRP-based)
- Occupational: ~20 mSv/year effective dose (averaged over defined periods); separate limits for lens of the eye (~20 mSv/yr under ICRP) and extremities/skin (~500 mSv/yr).
- Public: ~1 mSv/year effective dose.
- Declared pregnancy: additional constraint to protect the embryo/fetus (e.g., ~1 mSv over the declared term under some frameworks).
(Exact limits are set by the applicable regulator — NRC/Agreement States or national body — verify locally; US NRC occupational limit is 50 mSv/yr, differing from ICRP's 20.)
ALARA in Practice
- Time: minimize time near sources.
- Distance: the inverse-square law — doubling distance quarters exposure — is the most powerful lever.
- Shielding: lead for gamma; for beta emitters, low-Z material first (acrylic/plastic) then lead, because lead alone generates penetrating bremsstrahlung X-rays.
- Plus contamination control, dosimetry badges, and workflow design.
Worked Point
A tech stands 30 cm from a source reading 4 mR/hr. Stepping back to 90 cm (3×) drops exposure by 3² = 9×, to ~0.44 mR/hr — distance beats most shielding for quick gains.
Reporting / Practice Notes
- Frame diagnostic risk in effective dose terms; frame therapy limits in absorbed dose to organs at risk.
- Apply ALARA (time/distance/shielding) and document occupational dose (badges).
- Match shielding to emission (low-Z-then-lead for beta).
Common Pitfalls
- Applying deterministic-threshold thinking to stochastic (no-threshold) cancer risk — or vice versa.
- Shielding high-energy beta sources with lead alone (generates bremsstrahlung).
- Confusing NRC (50 mSv/yr) with ICRP (20 mSv/yr) occupational limits.
- Neglecting the inverse-square law as the cheapest dose-reduction tool.
Board Pearls
Radiation effects split into stochastic (probability of cancer/heritable harm rises with dose, no threshold under LNT, severity fixed) and deterministic/tissue reactions (occur above a threshold, severity rises with dose — skin injury, marrow suppression, cataract). Diagnostic nuclear medicine lives in the stochastic range managed by ALARA (time, distance, shielding); therapy dosimetry manages deterministic organ limits (marrow, kidney, lung, salivary).
Effective dose (Sv) weights equivalent dose by tissue radiosensitivity, letting disparate procedures compare on one stochastic-risk scale. The inverse-square law is the most powerful practical lever — tripling distance cuts exposure ~9×.
Keep the dose chain straight: absorbed dose (Gy) → equivalent dose (Sv) (radiation weighting; α = 20) → effective dose (Sv) (tissue weighting). Representative limits: ICRP ~20 mSv/yr occupational, ~1 mSv/yr public — but the US NRC uses 50 mSv/yr occupational, so verify the applicable regulator. For beta emitters, shield with low-Z first (acrylic) then lead; lead alone generates penetrating bremsstrahlung and worsens the exposure it was meant to stop.
Related Pages
- Physics: PET/SPECT performance, radiation safety & patient release; safety niches: contamination/accident management.
Figure / Diagram Suggestions
- A stochastic vs deterministic dose–response pair (probability vs severity curves).
- An inverse-square exposure-vs-distance plot.
- A beta-shielding schematic (acrylic-then-lead vs bremsstrahlung from lead alone).
Self-Check
Q1. Classify radiation-induced cancer vs cataract as stochastic or deterministic, and state the defining difference.
Answer: Cancer is stochastic (no threshold; probability rises with dose); cataract is deterministic (threshold; severity rises with dose above it).
Q2. Why must a high-energy beta source be shielded with acrylic before lead?
Answer: Lead alone generates penetrating bremsstrahlung X-rays; a low-Z material (acrylic) first stops the betas with minimal bremsstrahlung, then lead attenuates residual photons.
Q3. A source reads 8 mR/hr at 25 cm. Approximately what is it at 100 cm?
Answer: Distance ×4 → exposure ÷16 → about 0.5 mR/hr (inverse-square law).
Q4. What does effective dose (Sv) add beyond absorbed dose (Gy)?
Answer: It weights for radiation type (equivalent dose) and then tissue radiosensitivity (tissue weighting factors), giving a single whole-body stochastic-risk scale.
Evidence & sources
https://nuc.med/radiation-biology-protection/ Report an issue